[go: up one dir, main page]

MX2016000480A - Composiciones farmaceuticas de pancreatina de alta potencia. - Google Patents

Composiciones farmaceuticas de pancreatina de alta potencia.

Info

Publication number
MX2016000480A
MX2016000480A MX2016000480A MX2016000480A MX2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
high potency
pancreatin
pancreatin pharmaceutical
compositions
Prior art date
Application number
MX2016000480A
Other languages
English (en)
Inventor
Boltri Luigi
Ghidorsi Luigi
Pironti Vincenza
Perrett Stephen
Becker Robert
Arzuffi Paola
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53042009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016000480(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Publication of MX2016000480A publication Critical patent/MX2016000480A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención proporciona composiciones farmacéuticas de alta potencia que comprenden enzimas de pancreatina de alta actividad. La invención también se relaciona con un proceso para producir enzimas de HA-pancreatina y sus composiciones o formas de dosificación, y con métodos para su uso.
MX2016000480A 2013-11-05 2014-11-05 Composiciones farmaceuticas de pancreatina de alta potencia. MX2016000480A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361900092P 2013-11-05 2013-11-05
PCT/US2014/063984 WO2015069677A1 (en) 2013-11-05 2014-11-05 High potency pancreatin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2016000480A true MX2016000480A (es) 2016-10-21

Family

ID=53042009

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000480A MX2016000480A (es) 2013-11-05 2014-11-05 Composiciones farmaceuticas de pancreatina de alta potencia.

Country Status (13)

Country Link
EP (2) EP3003360B1 (es)
JP (1) JP2017500885A (es)
KR (1) KR20170052520A (es)
CN (1) CN106659773A (es)
AU (1) AU2014346930A1 (es)
BR (1) BR112016000658A2 (es)
CA (1) CA2915671A1 (es)
ES (1) ES2834483T3 (es)
HK (1) HK1222325A1 (es)
IL (3) IL243435B (es)
MX (1) MX2016000480A (es)
RU (1) RU2015155470A (es)
WO (1) WO2015069677A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
ES2560527T3 (es) 2007-02-20 2016-02-19 Allergan Pharmaceuticals International Limited Composiciones estables de enzimas digestivas
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
CL2011002432A1 (es) 2010-10-01 2012-04-20 Aptalis Pharma Ltd Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
EP2741766B1 (en) 2011-08-08 2015-10-07 Aptalis Pharma Limited Method for dissolution testing of solid compositions containing digestive enzymes
CN105392496A (zh) 2013-07-22 2016-03-09 阿普塔利斯制药有限公司 高效的胰酶药物组合物
EP3639846B1 (en) 2013-08-09 2022-09-28 Allergan Pharmaceuticals International Limited Digestive enzyme composition suitable for enteral administration
AU2015275860A1 (en) * 2014-06-19 2016-11-03 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2751330A (en) * 1952-08-27 1956-06-19 Armour & Co Use of a salt in the extraction slurry in recovering proteolytic enzymes from pancreas gland material
GB928654A (en) 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
US3168448A (en) 1963-01-07 1965-02-02 Wilson & Co Inc Process of preparing a lipolytic enzyme composition
DE2460334C3 (de) * 1974-12-20 1979-09-06 Hoechst Ag, 6000 Frankfurt Verfahren zur Gewinnung von Insulin und Pankreatin aus Schweinepankreas
EP0115023B1 (de) * 1982-12-30 1988-07-27 Nordmark Arzneimittel GmbH Verfahren zur Gewinnung von Pankreatin
FR2603804B1 (fr) * 1986-09-17 1989-10-27 Jouveinal Sa Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique
DE3927286C2 (de) * 1989-08-18 1997-07-24 Roehm Gmbh Wäßrige Enzym-Flüssigformulierungen
DE69634248T2 (de) 1995-05-31 2006-01-12 Medzyme N.V. Zusammensetzungen zur verbesserung der verdaulichkeit und ausnutzung von nähestoffen
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
WO2006044529A1 (en) * 2004-10-14 2006-04-27 Altus Pharmaceuticals Inc. Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
PL2278002T3 (pl) 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej
ES2560527T3 (es) * 2007-02-20 2016-02-19 Allergan Pharmaceuticals International Limited Composiciones estables de enzimas digestivas
BR112012023518A2 (pt) * 2010-03-19 2017-10-03 Aptalis Pharma Canada Inc Composição farmacêutica gastro- resistente compactada,monolítica, composição farmaceutica método para tratar um disturbio digestivo e método de controle da esteatorreia
CN102946872A (zh) * 2010-05-03 2013-02-27 阿普塔利斯制药有限公司 包含含有胰酶的消化酶混合物的微丸组合物
CL2011002432A1 (es) * 2010-10-01 2012-04-20 Aptalis Pharma Ltd Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos.
CN103060297B (zh) * 2012-12-28 2014-06-25 青岛九龙生物医药有限公司 一种分离纯化胰蛋白酶的方法
CN103060296B (zh) * 2012-12-30 2014-05-21 青岛九龙生物医药有限公司 从动物胰脏中提取胰蛋白酶的方法
CN105392496A (zh) * 2013-07-22 2016-03-09 阿普塔利斯制药有限公司 高效的胰酶药物组合物

Also Published As

Publication number Publication date
CA2915671A1 (en) 2015-05-14
HK1222325A1 (zh) 2017-06-30
AU2014346930A1 (en) 2016-01-07
IL243435A0 (en) 2016-03-31
RU2015155470A3 (es) 2018-09-10
IL274583B (en) 2022-06-01
JP2017500885A (ja) 2017-01-12
KR20170052520A (ko) 2017-05-12
EP3003360A1 (en) 2016-04-13
EP3613429A1 (en) 2020-02-26
IL284419A (en) 2021-07-29
WO2015069677A1 (en) 2015-05-14
IL243435B (en) 2020-06-30
EP3003360A4 (en) 2017-04-26
EP3003360B1 (en) 2020-10-07
ES2834483T3 (es) 2021-06-17
IL274583A (en) 2020-06-30
RU2015155470A (ru) 2017-08-21
CN106659773A (zh) 2017-05-10
BR112016000658A2 (pt) 2018-03-20

Similar Documents

Publication Publication Date Title
WO2015019198A3 (en) High potency pancreatin pharmaceutical compositions
MX2016000480A (es) Composiciones farmaceuticas de pancreatina de alta potencia.
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
SG10201907582WA (en) Bicyclic heterocycles as fgfr4 inhibitors
WO2014153346A8 (en) Engineering a heterogeneous tissue from pluripotent stem cells
IN2014DN08867A (es)
NZ720478A (en) Autotaxin inhibitor compounds
MX2016008448A (es) Conjugados de var2csa-farmaco.
IN2015KN00262A (es)
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
MX2019000536A (es) Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
PH12016500003A1 (en) Compounds and compositions as inhibitors of mek
PH12017501095A1 (en) Piperidine derivatives as hdac1/2 inhibitors
GEP201706621B (en) Benzamides
CA2878796C (en) Derivatives of pyridinone as inhibitors for tissue transglutaminase
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX2016006604A (es) Derivados de piperidina con actividad multimodal contra el dolor.
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2016005545A (es) Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo.